Market Place
Sourcing Support
All News #Library
Rare Diseases
UCB Reveals Epilepsy Patient Quality-Of-Life Impact Data At AAN
15 Apr 2026 //
PHARMIWEB
UCB receives positive CHMP opinion for new ZILBRYSQ
26 Mar 2026 //
PHARMIWEB
UCB Names PANTHERx Rare Exclusive KYGEVVI Specialty Pharmacy
23 Mar 2026 //
PR NEWSWIRE
EMA Seeks Input On Drafting Myasthenia Gravis Trial Guide
19 Feb 2026 //
RAPS
Results for UCB`s Fintepla pave way for 3rd epileptic indication
08 Dec 2025 //
FIERCE PHARMA
FDA Approves Kygevvi for TK2D in Adults & Children
07 Nov 2025 //
PR NEWSWIRE
FINTEPLA (OLE) Study Results In Lennox-Gastaut Syndrome Published
14 Oct 2025 //
PR NEWSWIRE
UCB presents TK2d research at UMDF 2025 Conference
20 Jun 2025 //
PR NEWSWIRE
PANTHERx® Rare Selected by UCB as the Exclusive Specialty Pharmacy for ZILBRYSQ
10 Jan 2024 //
PR NEWSWIRE
Huma and UCB partner to provide digital health solution to improve rare disease
26 Apr 2023 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.